Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT06277219 |
| Title | A First-in-Human, Phase 1/2 Study of LAT010 in Patients With Advanced Solid Tumors (LIGHTSPEED-1) (LIGHTSPEED-1) |
| Acronym | LIGHTSPEED-1 |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | No |
| Sponsors | Latticon Antibody Therapeutics, Inc |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| D&H Cancer Research Center | COMPLETED | Margate | Florida | 33063 | United States | Details |
| Huntsman Cancer Institute | TERMINATED | Salt Lake City | Utah | 84112 | United States | Details |
| Cancer Hospital of Shandong First Medical University | RECRUITING | Jinan | Shandong | 250117 | China | Details |
| The First Affiliated Hospital of Zhejiang University School of Medicine | RECRUITING | Hangzhou | Zhejiang | 310002 | China | Details |